Clinical Trial Update: Stem Cell Transplant for Immunologic or Histiocytic Disorders [Phase 2]

View source ↗

Summary

Phase 2 trial update on stem cell transplantation for immunologic or histiocytic disorders, with completed status and results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chediak-higashi Syndrome
• Griscelli Syndrome
• Hemophagocytic Lymphohistiocytosis
• Immunologic Deficiency Syndromes
• Langerhans Cell Histiocytosis
• X-linked Lymphoproliferative Disorders

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Hemophagocytic Lymphohistiocytosis, X-Linked Lymphoproliferative Disorders | Phase 2 | Status: COMPLETED | Results posted: 2017-04-14